Back to companies

AprilBio Co.,Ltd.

397030KRKRX

에이프릴바이오

Revenue
—
FY2024
Operating income
₩16.9bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)